Giuliano Rizzardini

Luigi Sacco Hospital — Italy

Medicine · Health Sciences

48h-index12.1kcitations408works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(133), HIV Research and Treatment(106), Hepatitis C virus research(101), HIV/AIDS Research and Interventions(60), HIV-related health complications and treatments(58)

Publications400 total

SAT-260 Autoimmunity in chronic hepatitis D: results from the HDV describe study cohort
Journal of Hepatology·2025
Optimization in the HIV treatment: economic and organizational impact analysis of Bictegravir/Emtricitabine/Tenofovir Alafenamide
Global & Regional Health Technology Assessment·2025Open Access
Evidence of durable response to bepirovirsen in B-Clear On-NA responders: B-Sure second report
Digestive and Liver Disease·2025
Autoimmunity in chronic HDV infection: results from the HDV Describe study cohort
Digestive and Liver Disease·2025
Burden and Risk Factors for Coinfections in Patients with a Viral Respiratory Tract Infection
Pathogens·2024· 7 citedOpen Access
High Symptom Burden in Patients With Advanced Chronic or Prolonged Infectious Diseases: Not Only Pain
Cureus·2024Open Access
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements
Microorganisms·2024· 5 citedOpen Access
Neurobrucellosis Presenting with Motor Damage or Hearing Loss, and Use of Steroids are Associated with a Higher Risk of Sequelae or Relapse: A Systematic Review of Individual Participant Data
Neurological Sciences·2024· 7 citedOpen Access
Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study
Medicina·2024· 1 citedOpen Access
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
The Lancet HIV·2024· 17 cited
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial
The Lancet HIV·2024· 19 cited
Ralstonia insidiosa Bacteremia in Patients with Solid Cancer Treated by Means of a Central Venous Catheter
Hygiene·2024· 2 citedOpen Access
Evaluation of analytical performance of the STANDARD <sup>TM</sup> M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of <i>Monkeypox virus</i>
Emerging Microbes & Infections·2024· 6 citedOpen Access
Surge of Mpox Cases in Lombardy Region, Italy, October 2023—January 2024
Clinical Infectious Diseases·2024· 3 citedOpen Access
First imported case of Candida auris infection in Milan, Italy: genomic characterisation
Infection·2024· 4 citedOpen Access
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy
Travel Medicine and Infectious Disease·2024· 10 citedOpen Access
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals
Journal of Antimicrobial Chemotherapy·2024· 9 cited
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease
Virology Journal·2024· 5 citedOpen Access
Switching to dolutegravir plus rilpivirine versus maintaining current antiretroviral therapy regimen in virologically suppressed people with HIV-1 and the Lys103Asn (K103N) mutation: 48-week results from a randomised, open-label pilot clinical trial
The Lancet HIV·2024· 3 citedOpen Access
Recurrent and fatal diarrhea caused by Cystoisospora belli in a man with HIV infection
HIV & AIDS Review·2024· 2 citedOpen Access
page 1 of 20Next →

Frequent Co-authors

Spinello Antinori(9), Massimo Galli(9), Jaime Andrade‐Villanueva(7), Kimberly Y. Smith(7), Mario Clerici(7), Andrea Giacomelli(6), Anna Lisa Ridolfo(6), Adriano Lazzarin(6), Luca Meroni(6), Stefania Piconi(6), Claudio Maria Mastroianni(6), Gary Richmond(5), Pedro Cahn(5), Susan L. Ford(5), Herta Crauwels(5), William Spreen(5), Daria Trabattoni(5), Letizia Oreni(4), Stefano Rusconi(4), Susan Swindells(4)